A flood of data indicate the importance and the relevance in both respiratory and extrapulmonary disease of Chlamydia pneumoniae infection today. Antibody prevalence rates in Western countries reach 50% in the adult population and remain high in old age suggesting a high rate of reinfection. Chlamydia pneumoniae can cause upper respiratory tract infections, like pharyngitis and sinusitis as well as bronchitis and more than 10% of community-acquired pneumonia. Recent data suggest a possible association of Chlamydia pneumoniae infection with wheezing and adult-onset asthma. However, the most intriguing hypothesis pertains the possible association between Chlamydia pneumoniae infection and atherosclerosis.

1 History of a New Agent of Pneumonia

2 Chlamydia pneumoniae Microbiology
3 Laboratory Diagnosis
4 Epidemiology
5 Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatment
6 Clinical Characteristics of Chlamydia pneumoniae Infection
7 Immunology of Chlamydia pneumoniae
8 Chronic Chlamydia pneumoniae Infections
9 Evidence for Chlamydia pneumoniae Infection in Asthma
10 Chlamydia pneumoniae Pneumonia: Radiological Features
11 Perspectives and Perceptions on the Clinical Relevance of Chlamydia pneumoniae Infection.